Barely Significant
← all excerpts

Evaluating the cellular targets of anti-4-1BB agonist antibody during immunotherapy of a pre-established tumor in mice.

PLoS One · 2010 · PMC2882368 · PMID 20543982

Europe PMCDOI
1
hedged sentence
0.1800
closest p · 3.6× alpha
0.1800
boldest claim

The sentences

showed a trendp = 0.18not close (p > 0.1)
The combination with T cells plus anti-4-1BB showed a trend towards increased survival over anti-4-1BB alone (80% survival; p = 0.18).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.